MedTech Dive August 25, 2025
From M&A to MDUFA and the developing market in renal denervation, MedTech Dive covers the key issues to watch in the final months of the year.
Halfway into the year, medical device companies are getting more clarity about what the rest of 2025 will hold.
After a slowdown in dealmaking in the spring, acquisitions are picking back up. Medtech companies are preparing for significant launches, with Medtronic ramping up its challenge to Intuitive Surgical’s robots and Medicare broadening coverage of a device-based treatment for high blood pressure.
Meanwhile, the Food and Drug Administration, under new leader Martin Makary, is starting to outline its regulatory approach and negotiate how much it will collect in fees from the industry in the...
Today's Sponsors
Today's Sponsor